Search

everythinglearnresearchcommunity

for

Search:↓

Glucocorticoids and thyroid hormones together are essential for fetal fat development.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Frontal fibrosing alopecia may be caused by an autoimmune reaction and hormonal imbalance.

Different diets change the fat composition in mouse skin, often reducing beneficial omega-3 fatty acids.

An American Bully with a genetic skin condition improved significantly with specific topical treatments.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Formononetin may help protect the brain and treat neurological diseases.

FOXN1 gene variants cause low T cells and immune issues from birth.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Phosphorylation controls TFEB's location in the cell, affecting cell metabolism and stress response.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Tenofovir alafenamide fumarate is effective and safer for hepatitis B, with fewer side effects than tenofovir disoproxil fumarate.

Mycophenolate mofetil improved skin condition in a man with nephrogenic fibrosing dermopathy.

Silencing NtNCED3-2 gene in tobacco reduces drought tolerance and impairs growth.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Radiation treatment causes skin fibrosis by increasing certain fibroblast subpopulations, but using a c-Jun inhibitor or fat grafting can reduce this effect.

Nfib in hair follicle stem cells boosts melanocyte stem cell growth and differentiation.

3,4,5-tri-O-caffeoylquinic acid promotes hair growth by activating the β-catenin pathway.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

More research needed to confirm finasteride as standard treatment for FFA.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

Blocking a key energy pathway in human hair follicles can trigger stress responses that stop cell growth.

Frontal Fibrosing Alopecia might be an autoimmune disease.

Genotyping for NUDT15 p.Arg139Cys can help predict thiopurine side effects in Japanese IBD patients.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

FFA can be mistaken for rosacea, requiring specific treatment for accurate diagnosis and management.

Introducing the rat OTC gene normalized hair growth in SPF-ASH mice.

New treatments for immune disorders caused by FOXN1 deficiency are promising.